Gene · 8505
Papers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-scale characterisation of homologous recombination deficiency in breast cancer. | Genome Med | 2023 | 37919776 | PubTator, text mining | PubMed |
| ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. | J Biol Chem | 2023 | 37898399 | PubTator, text mining | PubMed |
| Combination Treatment Strategies to Overcome PARP Inhibitor Resistance. | Biomolecules | 2023 | 37892162 | PubTator, text mining | PubMed |
| The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC. | Nucleic Acids Res | 2023 | 37889078 | PubTator, text mining | PubMed |
| An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors. | Pathogens | 2023 | 37887737 | PubTator, text mining | PubMed |
| DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions. | Curr Issues Mol Biol | 2023 | 37886943 | PubTator, text mining | PubMed |
| Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer. | Sci Adv | 2023 | 37878693 | PubTator, text mining | PubMed |
| PARP10 is Critical for Stress Granule Initiation. | bioRxiv | 2023 | 37873303 | PubTator, text mining | PubMed |
| Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer. | Transl Cancer Res | 2023 | 37859736 | PubTator, text mining | PubMed |
| O-GlcNAc has crosstalk with ADP-ribosylation via PARG. | J Biol Chem | 2023 | 37858678 | PubTator, text mining | PubMed |
| Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7. | Front Cell Dev Biol | 2023 | 37842082 | PubTator, text mining | PubMed |
| The Complex Network of ADP-Ribosylation and DNA Repair: Emerging Insights and Implications for Cancer Therapy. | Int J Mol Sci | 2023 | 37834477 | PubTator, text mining | PubMed |
| ADP-ribosylation from molecular mechanisms to therapeutic implications. | Cell | 2023 | 37832523 | PubTator, text mining | PubMed |
| ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. | Nucleic Acids Res | 2023 | 37823600 | PubTator, text mining | PubMed |
| Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. | J Exp Clin Cancer Res | 2023 | 37821935 | PubTator, text mining | PubMed |
| Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. | F1000Res | 2023 | 37799492 | PubTator, text mining | PubMed |
| Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges. | Front Oncol | 2023 | 37746296 | PubTator, text mining | PubMed |
| Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options. | Drugs | 2023 | 37737434 | PubTator, text mining | PubMed |
| RB loss sensitizes cells to replication-associated DNA damage after PARP inhibition by trapping. | Life Sci Alliance | 2023 | 37704395 | PubTator, text mining | PubMed |
| PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities. | Sci Adv | 2023 | 37703374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8505/papers?page=7